| Literature DB >> 33983709 |
Colin N Lam1, Misha G Mehta-Kolte2, Natacha Martins-Sorenson1, Barbara Eckert2, Patrick H Lin1, Kristina Chu2, Arrash Moghaddasi1, Dylan Goldman1, Hai Nguyen1, Ryan Chan1, Laxmi Nukala1, Shawn Suko2, Brett Hanson1, Richard Yuan1, Kyle C Cady1.
Abstract
Bacterial transduction particles were critical to early advances in molecular biology and are currently experiencing a resurgence in interest within the diagnostic and therapeutic fields. The difficulty of developing a robust and specific transduction reagent capable of delivering a genetic payload to the diversity of strains constituting a given bacterial species or genus is a major impediment to their expanded utility as commercial products. While recent advances in engineering the reactivity of these reagents have made them more attractive for product development, considerable improvements are still needed. Here, we demonstrate a synthetic biology platform derived from bacteriophage P1 as a chassis to target transduction reagents against four clinically prevalent species within the Enterobacterales order. Bacteriophage P1 requires only a single receptor binding protein to enable attachment and injection into a target bacterium. By engineering and screening particles displaying a diverse array of chimeric receptor binding proteins, we generated a potential transduction reagent for a future rapid phenotypic carbapenem-resistant Enterobacterales diagnostic assay.Entities:
Keywords: Smarticles; antimicrobial resistance; antimicrobial susceptibility testing; bacteriophage; carbapenem-resistant Enterobacterales; synthetic biology
Mesh:
Substances:
Year: 2021 PMID: 33983709 DOI: 10.1021/acssynbio.1c00036
Source DB: PubMed Journal: ACS Synth Biol ISSN: 2161-5063 Impact factor: 5.110